Brightree names new CEO
ATLANTA – Brightree announced its acquisition by ResMed earlier this year and now it has a new CEO.
Matt Mellott will take the lead at the software company, replacing current president and CEO Dave Cormack, who will transition to a multi-year advisory role.
Mellott joins Brightree from MedBridge Healthcare, a sleep disorder diagnostic testing and respiratory therapy company. In his 12 years at MedBridge, most recently as president, he helped to grow the company to include 140 sleep disorder centers and 21 HME locations across 22 states.
“Leading a home medical equipment provider has helped shape my understanding of what post-acute care providers value in a software partner,” he said in a press release. “I’m looking forward to sharing those insights, accelerating Brightree’s already impressive pace of innovation and further enhancing its customers’ ability to deliver exception care, while building lasting businesses.”
Prior to MedBridge, Mellott served in a variety of executive finance leadership and CFO roles. He began his career with KPMG, one of the Big Four accounting firms.
Cormack joined Brightree in 2005 and led the company through a period of tremendous growth, taking what was then a fledgling software-as-a-service startup with 12 employees and fewer than 100 customers into a company with revenues exceeding $100 million annually.
“Brightree wouldn’t be the company it is today without the leadership of Dave Cormack,” said Raj Sodhi, president of healthcare informatics at ResMed, in a statement. “We’re pleased Dave has agreed to stay on in an advisory role to ensure a smooth transition.”
In addition to Mellott, Brightree named Bobby Ghoshal COO. He will oversee the company’s technology, product management initiatives, business operations and finance functions. Ghoshal was previously vice president of information technology in ResMed’s Americas group.
“Matt Mellott and Bobby Ghoshal…will continue moving Brightree forward, expanding on the company’s leadership in business management and clinical software applications for the post-acute care industry,” Sodhi said.
Brightree was acquired by ResMed in April 2016.